| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Martin Göttle, Cecilia N Prudente, Rong Fu, Diane Sutcliffe, Hong Pang, Deborah Cooper, Emir Veledar, Jonathan D Glass, Marla Gearing, Jasper E Visser, H A Jinna. Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Annals of neurology. vol 76. issue 1. 2014-09-22. PMID:24891139. |
affected patients have a peculiar neurobehavioral syndrome linked with reductions of dopamine in the basal ganglia. |
2014-09-22 |
2023-08-13 |
human |
| Roger M Kurla. Treatment of Tourette syndrome. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. vol 11. issue 1. 2014-09-19. PMID:24043501. |
the underlying etiology and neurobiology of ts remain unknown although genetic factors appear to be important, cortical control of basal ganglia motor function appears to be disturbed and neurochemical abnormalities, particularly involving dopamine neurotransmission, are likely present. |
2014-09-19 |
2023-08-12 |
Not clear |
| D Dardou, S Monlezun, P Foerch, J P Courade, L Cuvelier, M De Ryck, S N Schiffman. A role for Sv2c in basal ganglia functions. Brain research. vol 1507. 2014-09-18. PMID:23458503. |
in the present study, we have investigated sv2c implication in both normal and pathological basal ganglia functioning with a peculiar attention to dopamine neuron containing regions. |
2014-09-18 |
2023-08-12 |
mouse |
| Matthew M Walsh, John R Anderso. Navigating complex decision spaces: Problems and paradigms in sequential choice. Psychological bulletin. vol 140. issue 2. 2014-09-01. PMID:23834192. |
the former class of techniques is understood in terms of the neurotransmitter dopamine and its effects in the basal ganglia. |
2014-09-01 |
2023-08-12 |
human |
| Limin Mao, Minglei Guo, Daozhong Jin, Bing Xue, John Q Wan. Group III metabotropic glutamate receptors and drug addiction. Frontiers of medicine. vol 7. issue 4. 2014-08-26. PMID:24078068. |
this review summarizes the data from recent studies on three group iii receptor subtypes (mglur4/7/8) expressed in the basal ganglia and analyzes their roles in the regulation of dopamine and glutamate signaling in the striatum and their participation in the addictive properties of three major classes of drugs (psychostimulants, alcohol, and opiates). |
2014-08-26 |
2023-08-12 |
Not clear |
| Miguel Valencia, Mario Chavez, Julio Artieda, J Paul Bolam, Juan Mena-Segovi. Abnormal functional connectivity between motor cortex and pedunculopontine nucleus following chronic dopamine depletion. Journal of neurophysiology. vol 111. issue 2. 2014-08-26. PMID:24174651. |
the activity of the basal ganglia is altered in parkinson's disease (pd) as a consequence of the degeneration of dopamine neurons in the substantia nigra pars compacta. |
2014-08-26 |
2023-08-12 |
rat |
| John-Stuart Brittain, Peter Brow. Oscillations and the basal ganglia: motor control and beyond. NeuroImage. vol 85 Pt 2. 2014-08-14. PMID:23711535. |
the basal ganglia share this predilection for rhythmic activity which, as we see in parkinson's disease, becomes further enhanced in the dopamine depleted state. |
2014-08-14 |
2023-08-12 |
Not clear |
| Clare Muireann Davidson, Annraoi M de Paor, Madeleine M Lower. Application of describing function analysis to a model of deep brain stimulation. IEEE transactions on bio-medical engineering. vol 61. issue 3. 2014-08-13. PMID:24557697. |
in parkinson's disease, increased functional connectivity and oscillatory activity occur within the basal ganglia as a result of dopamine loss. |
2014-08-13 |
2023-08-12 |
Not clear |
| Agata Ryterska, Marjan Jahanshahi, Magda Osma. What are people with Parkinson's disease really impaired on when it comes to making decisions? A meta-analysis of the evidence. Neuroscience and biobehavioral reviews. vol 37. issue 10 Pt 2. 2014-08-06. PMID:24157725. |
parkinson's disease (pd) is associated with motor and cognitive impairment caused by dopamine dysregulation in the basal ganglia. |
2014-08-06 |
2023-08-12 |
Not clear |
| Ronise M Santiago, Janaína Barbiero, Raisa W Gradowski, Suelen Bochen, Marcelo M S Lima, Cláudio Da Cunha, Roberto Andreatini, Maria A B F Vita. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Behavioural brain research. vol 259. 2014-08-04. PMID:24183944. |
the basal ganglia receives dopamine (da) inputs from the substantia nigra pars compacta (snpc), which is known to be impaired in pd patients. |
2014-08-04 |
2023-08-12 |
rat |
| Gabriela P Chaves-Kirsten, Caio H Y Mazucanti, Caroline C Real, Bruna M Souza, Luiz R G Britto, Andréa S Torrã. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats. PloS one. vol 8. issue 10. 2014-08-02. PMID:24116178. |
we believe that the structure-specific variation of cb1 in basal ganglia in the 6-hydroxydopamine pd model could be related to a compensatory process involving the gabaergic transmission, which is impaired due to the lack of dopamine. |
2014-08-02 |
2023-08-12 |
rat |
| Ibrahim Aliy. Secondary enuresis associated with chorea in a nigerian girl. Indian journal of psychological medicine. vol 36. issue 3. 2014-07-18. PMID:25035562. |
its exact pathophysiology is not completely understood, but it has been related to the effect of dopamine in the basal ganglia. |
2014-07-18 |
2023-08-13 |
Not clear |
| Pierre R Burkhar. Acute and subacute drug-induced movement disorders. Parkinsonism & related disorders. vol 20 Suppl 1. 2014-07-11. PMID:24262159. |
mechanisms underlying drug-induced movement disorders involve blockade, facilitation or imbalance of dopamine, serotonin, noradrenaline and cholinergic neurotransmission in the basal ganglia. |
2014-07-11 |
2023-08-12 |
Not clear |
| Simon M Vogt, Ulrich G Hofman. Neuromodulation of STDP through short-term changes in firing causality. Cognitive neurodynamics. vol 6. issue 4. 2014-07-04. PMID:24995051. |
chemical neuromodulators such as dopamine or acetylcholine are thought to signal changes between external reward and internal expectation to many brain regions, including the basal ganglia. |
2014-07-04 |
2023-08-13 |
Not clear |
| Joana E Coelho, Pedro Alves, Paula M Canas, Jorge S Valadas, Tatiana Shmidt, Vânia L Batalha, Diana G Ferreira, Joaquim A Ribeiro, Michael Bader, Rodrigo A Cunha, Frederico Simões do Couto, Luísa V Lope. Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety. Frontiers in psychiatry. vol 5. 2014-07-01. PMID:24982640. |
adenosine a2a receptors (a2ar) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine d2 receptors. |
2014-07-01 |
2023-08-13 |
human |
| Nathaniel S Miller, Youngbin Kwak, Nicolaas I Bohnen, Martijn L T M Müller, Praveen Dayalu, Rachael D Seidle. The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease. Behavioural brain research. vol 257. 2014-06-25. PMID:24076152. |
these findings provide further evidence for the role of the basal ganglia and dopamine in duration production and suggest that the degree of striatal dopaminergic denervation may explain the heterogeneity of performance between pd patients on the sensorimotor synchronization task. |
2014-06-25 |
2023-08-12 |
Not clear |
| Abdelhamid Benazzouz, Omar Mamad, Pamphyle Abedi, Rabia Bouali-Benazzouz, Jonathan Chetri. Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. Frontiers in aging neuroscience. vol 6. 2014-06-24. PMID:24860498. |
involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of parkinson's disease. |
2014-06-24 |
2023-08-13 |
Not clear |
| Abdelhamid Benazzouz, Omar Mamad, Pamphyle Abedi, Rabia Bouali-Benazzouz, Jonathan Chetri. Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. Frontiers in aging neuroscience. vol 6. 2014-06-24. PMID:24860498. |
it is well established that dopamine neurons in the snc innervate not only the striatum, which is the main target, but also other basal ganglia nuclei including the two segments of globus pallidus and the subthalamic nucleus (stn). |
2014-06-24 |
2023-08-13 |
Not clear |
| Abdelhamid Benazzouz, Omar Mamad, Pamphyle Abedi, Rabia Bouali-Benazzouz, Jonathan Chetri. Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. Frontiers in aging neuroscience. vol 6. 2014-06-24. PMID:24860498. |
based on recent experimental data from animal models of parkinson's disease in rodents and non-human primates and also from parkinsonian patients, this review summarizes current knowledge on the role of dopamine in the modulation of basal ganglia neuronal activity and also the role of dopamine depletion in these nuclei in the pathophysiology of parkinson's disease. |
2014-06-24 |
2023-08-13 |
Not clear |
| Hee Kyung Park, Sun J Chun. New perspective on parkinsonism in frontotemporal lobar degeneration. Journal of movement disorders. vol 6. issue 1. 2014-06-24. PMID:24868417. |
dopamine transporter (dat) imaging revealed decreased uptake of dat, and imaging findings indicated atrophic changes of the basal ganglia. |
2014-06-24 |
2023-08-13 |
human |